Asset Details
Do you wish to reserve the book?
Lupeol and pristimerin do not inhibit activation of the human sperm CatSper Ca(2+)-channel version 1; peer review: 3 approved with reservations
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Lupeol and pristimerin do not inhibit activation of the human sperm CatSper Ca(2+)-channel version 1; peer review: 3 approved with reservations
Do you wish to request the book?
Lupeol and pristimerin do not inhibit activation of the human sperm CatSper Ca(2+)-channel version 1; peer review: 3 approved with reservations
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Lupeol and pristimerin do not inhibit activation of the human sperm CatSper Ca(2+)-channel version 1; peer review: 3 approved with reservations
2022
Overview
Opposing findings have been published on the regulation of the sperm-specific Ca
2+ channel CatSper (cation channel of sperm) in human sperm cells by the plant triterpenoids lupeol and pristimerin. While the original study on this topic found these triterpenoids to act as potent inhibitors of human CatSper, subsequent studies have failed to replicate such an inhibitory effect. It has been suggested that these issues could in part be due to purity issues and/or batch variation between the plant-derived extracts of lupeol and pristimerin obtained for the studies. The aim of this study was to elucidate this controversy by investigating the batches of lupeol and pristimerin used in our previous study with state-of-the-art
1H-,
13C- and 2D-nuclear magnetic resonance (NMR) methods to reveal potential purity and/or batch variation issues. When comparing the NMR-spectra obtained from
1H-NMR and
13C-NMR with previously published NMR-spectra for lupeol and pristimerin, we could confirm that both the lupeol and pristimerin batch were ≥95 % pure. These results confirm the validity of the findings in our previous study for lupeol and pristimerin, showing that lupeol and pristimerin do not inhibit activation of CatSper in human sperm. In conclusion, using
1H-,
13C- and 2D-NMR methods, we confirm that the lupeol and pristimerin batches used in our previous study were ≥95 % pure and thereby fail to identify any purity issues and/or batch variation that could explain the observed inability of lupeol and pristimerin to inhibit activation of CatSper in human sperm.
Publisher
Faculty of 1000 Ltd
Subject
